The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis
Open accessAbstract
IMPORTANCE: Sepsis is considered to induce immune suppression, leading to increased susceptibility to secondary infections with associated late mortality. OBJECTIVE: To determine the clinical and host genomic characteristics, incidence, and attributable mortality of intensive care unit (ICU)-acquired infections in patients admitted to the ICU with or without sepsis. DESIGN, SETTING, AND PARTICIPANTS: Prospective observational study comprising consecutive admissions of more than 48 hours in 2 ICUs in the Netherlands from January 2011 to July 2013 stratified according to admission diagnosis (sepsis or noninfectious). MAIN OUTCOMES AND MEASURES: The primary outcome was ICU-acquired infection (onset >48 hours). Attributable mortality risk (fraction of mortality that can be prevented by elimination of the risk factor, acquired infection) was determined using time-to-event models accounting for competing risk. In a subset of sepsis admissions (n = 461), blood gene expression (whole-genome transcriptome in leukocytes) was analyzed at baseline and at onset of ICU-acquired infectious (n = 19) and noninfectious (n = 9) events. RESULTS: The primary cohort included 1719 sepsis admissions (1504 patients; median age, 62 years; interquartile range [IQR], 51-71 years]; 924 men [61.4%]). A comparative cohort included 1921 admissions (1825 patients, median age, 62 years; IQR, 49-71 years; 1128 men [61.8%] in whom infection was not present in the first 48 hours. Intensive care unit-acquired infections occurred in 13.5% of sepsis ICU admissions (n = 232) and 15.1% of nonsepsis ICU admissions (n = 291). Patients with sepsis who developed an ICU-acquired infection had higher disease severity scores on admission than patients with sepsis who did not develop an ICU-acquired infection (Acute Physiology and Chronic Health Evaluation IV [APACHE IV] median score, 90 [IQR, 72-107] vs 79 [IQR, 62-98]; P < .001) and throughout their ICU stay but did not have differences in baseline gene expression. The population attributable mortality fraction of ICU-acquired infections in patients with sepsis was 10.9% (95% CI, 0.9%-20.6%) by day 60; the estimated difference between mortality in all patients with a sepsis admission diagnosis and mortality in those without ICU-acquired infection was 2.0% (95% CI, 0.2%-3.8%; P = .03) by day 60. Among nonsepsis ICU admissions, ICU-acquired infections had a population attributable mortality fraction of 21.1% (95% CI, 0.6%-41.7%) by day 60. Compared with baseline, blood gene expression at the onset of ICU-acquired infections showed reduced expression of genes involved in gluconeogenesis and glycolysis. CONCLUSIONS AND RELEVANCE: Intensive care unit-acquired infections occurred more commonly in patients with sepsis with higher disease severity, but such infections contributed only modestly to overall mortality. The genomic response of patients with sepsis was consistent with immune suppression at the onset of secondary infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Oostdijk, E. A. N., Kesecioglu, J., Schultz, M. J., Visser, C. E., de Jonge, E., van Essen, E. H. R., Bernards, A. T., Purmer, I., Brimicombe, R., Bergmans, D., et al. (2014) · JAMA · doi:10.1001/jama.2014.7247 · Cited by 175
Self-citationRetractedR: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
limma: Linear Models for Microarray Data
Smyth, G. K. (2005) · Statistics for Biology and Health · doi:10.1007/0-387-29362-0_23 · Cited by 5,796
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772
Tutorial in biostatistics: competing risks and multi‐state models
Putter, H., Fiocco, M., & Geskus, R. B. (2007) · Statistics in Medicine · doi:10.1002/sim.2712 · Cited by 2,440
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
Boomer, J. S., To, K., Chang, K. C., Takasu, O., Osborne, D. F., Walton, A. H., Bricker, T. L., Jarman, S. D., Kreisel, D., Krupnick, A. S., et al. (2011) · JAMA · doi:10.1001/jama.2011.1829 · Cited by 1,781
Zimmerman, J. E., Kramer, A. A., McNair, D. S., & Malila, F. M. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000215112.84523.f0 · Cited by 1,764
Vincent, J.-L. (1995) · JAMA · doi:10.1001/jama.1995.03530080055041 · Cited by 1,632
Kaukonen, K.-M., Bailey, M., Suzuki, S., Pilcher, D., & Bellomo, R. (2014) · JAMA · doi:10.1001/jama.2014.2637 · Cited by 1,459
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
Vincent, J.-L., Marshall, J. C., Ñamendys-Silva, S. A., François, B., Martin-Loeches, I., Lipman, J., Reinhart, K., Antonelli, M., Pickkers, P., Njimi, H., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70061-x · Cited by 1,252
Metabolism of Inflammation Limited by AMPK and Pseudo-Starvation
O'Neill, L. A. J., & Hardie, D. G. (2013) · Nature · doi:10.1038/nature11862 · Cited by 1,133
Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., Gaynes, R. P., & System, N. N. I. S. (2000) · Infection Control & Hospital Epidemiology · doi:10.1086/501795 · Cited by 1,028
Calandra, T., & Cohen, J. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000168253.91200.83 · Cited by 839
Decontamination of the digestive tract and oropharynx in ICU patients
de Smet, A. M. G. A., Kluytmans, J. A. J. W., Cooper, B. S., Mascini, E. M., Benus, R. F. J., van der Werf, T. S., van der Hoeven, J. G., Pickkers, P., Bogaers-Hofman, D., van der Meer, N. J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0800394 · Cited by 813
Self-citationWhy have clinical trials in sepsis failed?
Marshall, J. C. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.01.007 · Cited by 805
Sepsis: Current Dogma and New Perspectives
Deutschman, C. S., & Tracey, K. J. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.001 · Cited by 677
The Warburg effect then and now: From cancer to inflammatory diseases
Palsson‐McDermott, E. M., & O'Neill, L. A. J. (2013) · BioEssays · doi:10.1002/bies.201300084 · Cited by 537
A Molecular Biomarker to Diagnose Community-acquired Pneumonia on Intensive Care Unit Admission
Scicluna, B. P., Klein Klouwenberg, P. M. C., van Vught, L. A., Wiewel, M. A., Ong, D. S. Y., Zwinderman, A. H., Franitza, M., Toliat, M. R., Nürnberg, P., Hoogendijk, A. J., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201502-0355oc · Cited by 247
Self-citationLeentjens, J., Kox, M., van der Hoeven, J. G., Netea, M. G., & Pickkers, P. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201301-0036cp · Cited by 239
The new normal: immunomodulatory agents against sepsis immune suppression
Hutchins, N. A., Unsinger, J., Hotchkiss, R. S., & Ayala, A. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.01.002 · Cited by 239
Klouwenberg, P. M. C. K., Ong, D. S. Y., Bos, L. D. J., de Beer, F. M., van Hooijdonk, R. T. M., Huson, M. A., Straat, M., van Vught, L. A., Wieske, L., Horn, J., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182923712 · Cited by 218
Self-citationOpal, S. M., Dellinger, R. P., Vincent, J.-L., Masur, H., & Angus, D. C. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000325 · Cited by 191
Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma
Vanzant, E. L., Lopez, C. M., Ozrazgat-Baslanti, T., Ungaro, R., Davis, R., Cuenca, A. G., Gentile, L. F., Nacionales, D. C., Cuenca, A. L., Bihorac, A., et al. (2014) · Journal of Trauma and Acute Care Surgery · doi:10.1097/ta.0b013e3182ab1ab5 · Cited by 179
Klouwenberg, P. M. C. K., van Mourik, M. S. M., Ong, D. S. Y., Horn, J., Schultz, M. J., Cremer, O. L., & Bonten, M. J. M. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201307-1376oc · Cited by 153
Self-citationClinical review: Sepsis and septic shock - the potential of gene arrays
Wong, H. R. (2012) · Critical Care · doi:10.1186/cc10537 · Cited by 73
Schumacher, M., Wangler, M., Wolkewitz, M., & Beyersmann, J. (2007) · PubMed · Cited by 64
NLRP3 and ASC Differentially Affect the Lung Transcriptome during Pneumococcal Pneumonia
van Lieshout, M. H. P., Scicluna, B. P., Florquin, S., & van der Poll, T. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0015oc · Cited by 46
Self-citationMultilevel competing risk models to evaluate the risk of nosocomial infection
Wolkewitz, M., Cooper, B. S., Palomar, M., Álvarez-Lerma, F., Olaechea‐Astigarraga, P., Barnett, A. G., Harbarth, S., & Schumacher, M. C. (2014) · Critical Care · doi:10.1186/cc13821 · Cited by 34
Decontamination of the Digestive Tract and Oropharynx in ICU Patients
Kumar, A., & Funk, D. R. (2010) · Yearbook of Critical Care Medicine · doi:10.1016/s0734-3299(09)79320-7 · Cited by 12
Cited by
The immunopathology of sepsis and potential therapeutic targets
van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P., & Netea, M. G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.36 · Cited by 1,957
Self-citationAdvances in the understanding and treatment of sepsis-induced immunosuppression
Venet, F., & Monneret, G. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.165 · Cited by 981
The immune system’s role in sepsis progression, resolution, and long-term outcome
Delano, M. J., & Ward, P. A. (2016) · Immunological Reviews · doi:10.1111/imr.12499 · Cited by 880
Mechanisms and treatment of organ failure in sepsis
Lelubre, C., & Vincent, J.-L. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0005-7 · Cited by 852
Scicluna, B. P., van Vught, L. A., Zwinderman, A. H., Wiewel, M. A., Davenport, E. E., Burnham, K. L., Nürnberg, P., Schultz, M. J., Horn, J., Cremer, O. L., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30294-1 · Cited by 672
Self-citation
Metadata
- Authors
- van Vught, L. A., Klein Klouwenberg, P. M. C., Spitoni, C., Scicluna, B. P., Wiewel, M. A., Horn, J., Schultz, M. J., Nürnberg, P., Bonten, M. J. M., Cremer, O. L., van der Poll, T., & for the MARS Consortium
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-04-12
- Volume
- 315
- Issue
- 14
- Pages
- 1469
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2301209689
- Cited by
- 528
- References
- 35
- FWCI
- 47.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.